An innovative phase 2 chronic pain master protocol design to assess novel mechanisms in multiple pain types
By evaluating novel mechanisms across different pain types, therapeutic potential can be assessed more efficiently compared with traditional individual clinical studies.
Authors
- Laurence Anthony (ORCID: https://orcid.org/0000-0002-8249-2824)
- Kelly L. Knopp (ORCID: https://orcid.org/0000-0002-0632-6357)
- Karen Price (ORCID: https://orcid.org/0000-0002-8113-1461)
- AnnCatherine M. Downing
- Saptarshi Chaterjee
- JonDavid Sparks
Institutions
- Eli Lilly (United States) (US)
Publication Details
- Journal
- PAIN Reports
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1097/pr9.0000000000001203
- Citations
- 2
- Primary Topic
- Veterinary Pharmacology and Anesthesia
- Type
- article
- Field-Weighted Citation Impact
- 1.28
Funders
- Eli Lilly and Company